Performance of the Pooled Cohort Equations in non-alcoholic fatty liver disease: The Multi-Ethnic Study of Atherosclerosis

被引:2
|
作者
Henson, Jacqueline B. B. [1 ,5 ]
Budoff, Matthew J. J. [2 ,3 ]
Muir, Andrew J. J. [1 ,4 ]
机构
[1] Duke Univ, Dept Med, Div Gastroenterol, Durham, NC USA
[2] Harbor UCLA Med Ctr, Div Cardiol, Torrance, CA USA
[3] Lundquist Inst Biomed Innovat, Torrance, CA USA
[4] Duke Clin Res Inst, Durham, NC USA
[5] Duke Univ, Dept Med, Div Gastroenterol, DUMC 3913, Durham, NC 27710 USA
基金
美国国家卫生研究院;
关键词
atherosclerosis; cardiovascular diseases; non-alcoholic fatty liver disease; primary prevention; risk assessment; CARDIOVASCULAR RISK; ASSOCIATION; CALIBRATION;
D O I
10.1111/liv.15480
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and AimsNon-alcoholic fatty liver disease (NAFLD) is associated with a high risk of cardiovascular disease. Whether risk scores developed in the general population accurately assess cardiovascular risk in the NAFLD population is unknown. This study aimed to evaluate the performance of the Pooled Cohort Equations (PCE) in NAFLD. MethodsIndividuals in the Multi-Ethnic Study of Atherosclerosis with baseline non-contrast cardiac computed tomography scans with sufficient data to determine the presence of hepatic steatosis were identified and assessed for the development of incident 10-year atherosclerotic cardiovascular disease. The discrimination and calibration of the PCE were evaluated, and the observed and expected events by risk category (<5%, 5-<7.5%, 7.5-<20%, >= 20%) were determined. Risk reclassification with the addition of NAFLD to the PCE was assessed. ResultsOf 4014 participants included, 698 (17.4%) with NAFLD were identified, including 247 (35.3%) with moderate-to-severe steatosis. Discrimination of the PCE was suboptimal in NAFLD (c-statistic 0.69), particularly moderate-to-severe steatosis (0.65), and calibration was overall poor. While risk was overestimated in non-NAFLD, it was underestimated in NAFLD in lower/intermediate risk categories, predominantly in women (5-<7.5% observed/expected ratio = 1.67). The addition of NAFLD to the PCE improved risk classification in women. ConclusionsThe PCE overall performed suboptimally in cardiovascular risk assessment in NAFLD, particularly in women and individuals with moderate-to-severe steatosis in clinically relevant risk categories. Primary prevention may need to be considered at a lower risk threshold in these groups, and further work is needed to improve risk stratification in this growing high-risk population.
引用
收藏
页码:599 / 607
页数:9
相关论文
共 50 条
  • [41] Non-alcoholic Fatty Liver Disease and Its Links with Inflammation and Atherosclerosis
    Luan Rodrigues Abdallah
    Ricardo Cardoso de Matos
    Yves Pacheco Dias March e Souza
    Débora Vieira-Soares
    Gabriela Muller-Machado
    Priscila Pollo-Flores
    [J]. Current Atherosclerosis Reports, 2020, 22
  • [42] Ceramide as a Mediator of Non-Alcoholic Fatty Liver Disease and Associated Atherosclerosis
    Kasumov, Takhar
    Li, Ling
    Li, Min
    Gulshan, Kailash
    Kirwan, John P.
    Liu, Xiuli
    Previs, Stephen
    Willard, Belinda
    Smith, Jonathan D.
    McCullough, Arthur
    [J]. PLOS ONE, 2015, 10 (05):
  • [43] Non-alcoholic Fatty Liver Disease and Its Links with Inflammation and Atherosclerosis
    Abdallah, Luan Rodrigues
    de Matos, Ricardo Cardoso
    e Souza, Yves Pacheco Dias March
    Vieira-Soares, Debora
    Muller-Machado, Gabriela
    Pollo-Flores, Priscila
    [J]. CURRENT ATHEROSCLEROSIS REPORTS, 2020, 22 (01)
  • [44] Non-Alcoholic Fatty Liver Disease and Subclinical Atherosclerosis in Mexican Americans
    Gill, Clarence D.
    Vatcheva, Kristina P.
    Pan, Jen-Jung
    Smulevitz, Beverly
    Fallon, Michael B.
    McPherson, David D.
    McCormick, Joseph B.
    Fisher-Hoch, Susan P.
    Laing, Susan T.
    [J]. CIRCULATION, 2016, 134
  • [45] Non-alcoholic fatty liver disease: a metabolic burden promoting atherosclerosis
    Zhang, Lei
    She, Zhi-Gang
    Li, Hongliang
    Zhang, Xiao-Jing
    [J]. CLINICAL SCIENCE, 2020, 134 (13): : 1775 - 1799
  • [46] Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosis
    Sao, Rahul
    Aronow, Wilbert S.
    [J]. ARCHIVES OF MEDICAL SCIENCE, 2018, 14 (06) : 1233 - 1244
  • [47] Pooled cohort analysis of non-alcoholic fatty liver disease in patients with type 2 diabetes and the associated diagnostic performance of FibroScan
    Czernichow, S.
    Harrison, S. A.
    Allison, A. I.
    Tsochatzis, E.
    Anstee, Q. M.
    Sheridan, D.
    Guha, I. N.
    Cobbold, J.
    Paradis, V.
    Bedossa, P.
    Barsamian, C.
    Paredes, A. H.
    Newsome, P. N.
    [J]. DIABETOLOGIA, 2018, 61 : S581 - S582
  • [48] Non-alcoholic fatty liver disease
    Angulo, P
    Lindor, KD
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2002, 17 : S186 - S190
  • [49] Non-alcoholic Fatty Liver Disease
    Tan, Hui-Hui
    Chang, Jason Pik-Eu
    [J]. PROCEEDINGS OF SINGAPORE HEALTHCARE, 2010, 19 (01) : 36 - 50
  • [50] Non-alcoholic fatty liver disease
    Maurice, James
    Manousou, Pinelopi
    [J]. CLINICAL MEDICINE, 2018, 18 (03) : 245 - 250